Hopp til innhold
NHI.no
Annonse

Kreftfaresignaler hos barn: Hva gjør legen?

Innhold i artikkelen

Hvis mistanken om kreft opprettholdes etter at fastlegen har klargjort sykehistorie, utført legeundersøkelse og eventuelt tatt blodprøver, er det alltid nødvendig med øyeblikkelig hjelp innleggelse på nærmeste barneavdeling for videre utredning.

Annonse

I Norge som i de øvrige land i Vest-Europa, er barnekreftbehandlingen organisert i barnekreftsentre (fem regionale sentre) der man følger forhåndsdefinerte behandlingsprotokoller.

Dette dokumentet er basert på det profesjonelle dokumentet Kreftfaresignaler hos barn . Referanselisten for dette dokumentet vises nedenfor

  1. Helgestad J, Madsen B. Kreftoverlevelse hos barn. Tidsskr Nor Lægeforen 2005; 125: 2491-2. PubMed
  2. Fragkandrea I, Nixon JA, Panagopoulou P. Signs and symptoms of childhood cancer: a guide for early recognition. Am Fam Physician 2013; 88: 185-92. American Family Physician
  3. Stiller CA, Marcos-Gragera R, Ardanaz E, et al. Geographical patterns of childhood cancer incidence in Europe, 1988–1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006; 42: 1952–1960.
  4. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev 2010; 36: 277–285.
  5. Steuber CP. Clinical assessment of the child with suspected cancer. UpToDate, last updated Nov 14, 2019. UpToDate
  6. Bernbeck B, Wüller D, Janssen G, Wessalowski R, Göbel U, Schneider DT. Symptoms of childhood acute lymphoblastic leukemia: red flags to recognize leukemia in daily practice. Klin Padiatr. 2009;221(6):369–373. DOI: 10.1055/s-0029-1239538. DOI
  7. Gaddey HL, Riegel AM. Unexplained Lymphadenopathy: Evaluation and Differential Diagnosis. Am Fam Physician. 2016 Dec 1;94(11):896-903. PMID: 27929264. PubMed
  8. Wilne SH, Ferris RC, Nathwani A, Kennedy CR. The presenting features of brain tumours: a review of 200 cases. Arch Dis Child. 2006;91(6):502–506.
  9. Wilne S, Collier J, Kennedy C, Koller K, Grundy R, Walker D. Presentation of childhood CNS tumours: a systematic review and meta-analysis. Lancet Oncol. 2007;8(8):685–695.
  10. Nazemi KJ, Malempati S. Emergency department presentation of childhood cancer. Emerg Med Clin North Am. 2009;27(3):477–495.
  11. Shohet JM, Nuchtern JG. Clinical presentation, diagnosis, and staging evaluation of neuroblastoma. UpToDate, last updated Oct 15, 2020. UpToDate
  12. Wang LL, Gebhardt MC, Rainusso N. Osteosarcoma: Epidemiology, pathogenesis, clinical presentation, diagnosis, and histology. UpToDate, last updated Jul 16, 2019. UpToDate
  13. Singh T, Satheesh CT, Appaji L, et al. Langerhan's cell histiocytosis: a single institutional experience. Indian J Med Paediatr Oncol. 2010;31(2):51–53.
  14. Galli-Tsinopoulou A, Panagopoulou P, Stylianou C, Rafaelidou M, Vezyroglou C, Nousia-Arvanitakis S. P2-766 pituitary. Germinoma of the central nervous system (CNS): early endocrine manifestations abstract. Horm Res. 2005;64(suppl 1):223–224.
  15. Karavitaki N, Cudlip S, Adams CB, Wass JA. Craniopharyngiomas. Endocr Rev. 2006;27(4):371–397.
Annonse
Annonse